NCT01287793 - Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Healthy

Interventions

DRUG

tigecycline

intravenous, 200 mg, single dose

DRUG

tigecycline

intravenous, 50 mg, single dose

DRUG

moxifloxacin

oral tablet, 400 mg, single dose

DRUG

100 mL 0.9% Sodium Chloride intravenous

intravenous fluid, 100 mL, single dose

DRUG

placebo

0.9% Sodium Chloride intravenous 100mL, single dose

Trial Locations (1)

Pfizer Investigational Site, New Haven